Navigation Links
BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury
Date:9/8/2009

HERNDON, Va., Sept. 8 /PRNewswire/ -- BHR Pharma, LLC (BHR) announced today that it will initiate a global, Phase 3, multi-center pivotal trial (www.synapse-trial.com) to evaluate the effectiveness of its proprietary BHR-100 intravenous progesterone infusion product as a neuroprotective agent for treating severe traumatic brain injury (TBI) patients in early 2010.

BHR will enroll approximately 1,200 patients with severe (Glasgow Coma Scale scores of 4-8), closed-head trauma TBI at 100-120 medical centers in the United States, Europe, Israel and additional countries.

Randomized patients will receive a five-day (120-hour) intravenous infusion of progesterone or placebo. Unlike intravenous progesterone infusions described in the medical literature, BHR-100 is a ready-to-use infusion designed to meet all U.S. Food and Drug Administration approval requirements.

BHR is collaborating with the American Brain Injury Consortium (ABIC) and the European Brain Injury Consortium (EBIC) to identify the trial sites and help design the clinical study. PRA International is the Contract Research Organization for the trial.

TBI is a non-degenerative, non-congenital insult to the brain from an external mechanical force, possibly leading to permanent or temporary impairments of cognitive, physical and psychosocial functions with an associated diminished or altered state of consciousness.

Approximately 1.5 million Americans per year suffer a traumatic brain injury, resulting in 50,000 deaths, 235,000 hospitalizations and 80,000 cases of long-term disability. Incidence of TBI in all industrialized countries is comparable to that in the U.S., with estimates ranging from 150 to more th
'/>"/>

SOURCE BHR Pharma, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DOR BioPharma Announces NIH Grant Award to Support Phase 1/2 Clinical Trial of DOR201 in Radiation Enteritis
2. LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge
3. Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
4. Nitec Pharma Reports Positive and Highly Significant Phase III Results From Capra-2 Study of Lodotra(TM) in RA
5. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
6. Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009
7. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
8. ISTA Pharmaceuticals Announces Positive Preliminary Phase 3 Clinical Results to Support sNDA Filing for Once-Daily Xibrom(TM) 0.09%
9. Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
10. NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting
11. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... The Haselmeier Group has decided to reinforce ... has been nominated by the Board of Directors ... (CEO) of the Haselmeier Group. This nomination is ... brings more than 20 years of experience in the ... management positions, the last being Managing Director and Vice ...
(Date:6/30/2015)... -- Inventor of ProTide technology ...   NuCana, a clinical stage biopharmaceutical company ... portfolio of novel anti-cancer medicines, today announced the appointment ... Officer. Professor McGuigan was the original inventor ... Medicinal Chemistry at the Cardiff School of Pharmacy and ...
(Date:6/30/2015)... Ansell, a global leader in protection solutions, ... Ansell Cares ® H.E.R.O. Service Award ... organised in partnership with the European Operating Room Nurses ... and quality in patient care, and present an in-depth ... taking place today in the winners, respective hospitals in ...
Breaking Medicine Technology:Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3Ansell Announces European O.R. Nurse Hero Award Winners 2Ansell Announces European O.R. Nurse Hero Award Winners 3
... SAN DIEGO, May 5, 2011 /PRNewswire/ -- Halozyme ... developing and commercializing products targeting the extracellular matrix , ... of America Merrill Lynch Health Care Conference in Las Vegas. ... PDT (2:10 p.m. EDT). To listen to the live webcast ...
... 2011 Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) ... 31, 2011.  Savient ended the quarter with $268.0 million in ... December 31, 2010, primarily due to the issuance and sale ... the first quarter of 2011, the Company had a net ...
Cached Medicine Technology:Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12 2Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 2Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 3Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 4Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 5Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 6Savient Pharmaceuticals Reports First Quarter 2011 Financial Results 7
(Date:7/1/2015)... ... July 01, 2015 , ... This ... Patient Self-Management (PSM) Solutions at the Society for Human Resource Management (SHRM) Annual ... for over 10 years, can reduce overall cost of care by approximately $1,000 ...
(Date:6/30/2015)... ... July 01, 2015 , ... Avid boxing style rock ... Jimi Hendrix Singer Bowl concert posters. The Who and the Rascals also played at ... According to Hawley, "The Doors played with the Who backing them up. The Doors ...
(Date:6/30/2015)... (PRWEB) , ... July 01, 2015 , ... ... it more responsive and easy to navigate. By making fundamental changes to the ... A representative from the site said, “Finding the right website has been getting ...
(Date:6/30/2015)... ... 2015 , ... Ticket Down is a reliable source for cheap tickets for Journey at ... legendary band has been packing venues for years and they are one of the most ... albums in their career. While Journey is known for their all-around great sound, fans ...
(Date:6/30/2015)... ... ... The Blue Cross and Blue Shield of Minnesota Foundation today announced the award ... community health by focusing on the social and economic factors that greatly affect health ... year in 2016 based on progress in 2015. , “We took a new approach ...
Breaking Medicine News(10 mins):Health News:APhA Foundation to Showcase Newly Introduced Patient Self-Management Solutions at the Society for Human Resource Management (SHRM) Annual Conference and Exposition 2Health News:Avid Boxing Style Rock Concert Poster Collector From Vintage Rock Posters Announces Search for 1968 Doors and Jimi Hendrix Singer Bowl Concert Posters 2Health News:HerpesDatingSites.org Introduces a New Responsive Design 2Health News:Journey Tickets at The Stadium of Fire at Lavell Edwards Stadium in Provo, Utah: Ticket Down Slashes Ticket Prices for Journey on the 4th of July in Provo 2Health News:Blue Cross and Blue Shield of Minnesota Foundation Awards $1.5 Million 2
... domestic violence endure significantly higher health costs than other women ... finds. Abuse victims had health care costs that averaged ... years after the abuse ended and about $400 above others ... physical and emotional consequences even years after their abuse ends, ...
... healthy, financially secure and with a desire to travel. According ... remain among the most self-reliant generations to reach their golden ... They won,t stop being self-reliant when they get old and ... as he,s done at various national and international conferences. ...
... some patients suffered side effects, including reduced strength after ... -- Botulinum toxin, which smoothes facial wrinkles through injections ... suffer from "tennis elbow," a new study finds. , ... carefully, and there,s a potentially nettlesome side effect, according ...
... Adult content changes kids, personalities, one expert says, , ... allowed to watch R-rated movies are much less likely ... new study suggests. , Researchers questioned nearly 3,600 middle-school ... later. In that time, 3 percent of the kids ...
... and Springer Science+Business Media have launched a new textbook ... language set is of fundamental significance for the subject. ... the School of Chinese Medicine HKBU, the books were ... China and the USA. Representatives from HKBU, as well ...
... April 2010 - Elsevier, the world-leading publisher of ... proudly announces the release of a brand-new single ... mitral valve disease by the internationally renowned cardiac ... will launch at the 90th Annual Meeting of ...
Cached Medicine News:Health News:Domestic violence victims have higher health costs for years after abuse ends 2Health News:Domestic violence victims have higher health costs for years after abuse ends 3Health News:Baby boomers aging to be self-reliant 2Health News:Botox Injections May Relieve Tennis Elbow Pain 2Health News:Watching R-Rated Movies May Lead to Early Alcohol Use 2Health News:Springer Asia launches Chinese medicine textbook series in English 2Health News:Elsevier launches Carpentier's reconstructive valve surgery book 2
Designed to be removed from under surgical gown without compromising sterile fields. Two straps criss-cross in the back and attach with velcro in the front....
Wolfs unique apron and vest set distributes weight evenly between shoulders and hips. The vest comes with an attached Thyroid collar...
... Full frontal protection, our conventional ... shoulders by sturdy 2 webbed ... quick-acting snap hook fasteners. The ... custom fit the apron. Our ...
... Aprons are the result of a technologically ... x-ray aprons. Constructed with a wear resistant, ... the Lead Free aprons exhibit the same ... Each apron weighs approximately 50% less than ...
Medicine Products: